Where does Burke Neurological Institute rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Burke Neurological Institute ranks #31,108 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Burke Neurological Institute hold?

Burke Neurological Institute holds 8 US utility patents granted between 2021 and 2025, spanning 5 technology areas.

What is Burke Neurological Institute's Innovation Score?

Burke Neurological Institute has an Innovation Score of 46.5 out of 100 (top 21% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Burke Neurological Institute's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Burke Neurological Institute.

What does claim depth mean for Burke Neurological Institute's patents?

Burke Neurological Institute's patents average 18.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Burke Neurological Institute patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Burke Neurological Institute

Q: What technology areas does Burke Neurological Institute focus on?

Burke Neurological Institute's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 6 patents. Grants appear in 5 CPC subclasses total.

USPTO PatentsView assignee record - 8 granted patents across 5 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Burke ranks #31,108 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 5 technology areas.

#31,108
of 49,997 US assignees by volume: Top 21%
by Innovation Score (46.5/100): 18.4
avg claims per patent

USPTO PatentsView assignee plate

Corpus R31108 · US Corporation #31,108 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 8 grants
MID-PACK #31,108/49,997
PHOTO-FINISH Bryx
CPC-NARROW A61P · 5 areas
INNOV-PAR 46.5/100
CLAIMS-RICH 18.4 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2021–2025 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Bryx, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Burke Neurological… · this assignee

47
3D Lighting… · lowest

7

What this shows Burke's Innovation Score is 46.5/100 (top 21% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Burke's grants concentrate

Burke Neurological Institute is a focused PatentsView assignee: 5 CPC subclasses with 75% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2024 (4 grants) versus a trough of 1 in 2021. By volume, Burke sits between Bryx, Inc. and Byton North America Corporation.

Burke's three-year grant acceleration

Burke Neurological Institute shows 6 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Bryx

8
Buemach Engineeri…

8
Bulk Unlimited

8
Bullard Spine

8
Burnham Institute…

8
Button

8
Butts Properties

8
Byton North Ameri…

8
Burke Neurologica… ◀

8

What this shows Burke holds 8 patents at rank #31,109, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Burke

By rank, the assignees closest to #31,109 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Burke's primary technology class.

Burke's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

47 Top 21% higher than 79% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Burke Neurological Institute patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	1	12.5%
2023	2	25.0%
2024	4	50.0%
2025partial year	1	12.5%

Which technologies does Burke Neurological Institute patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 6

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 6

A61B - DIAGNOSIS; SURGERY; Identification 2

C07K - Peptides 2

G09G - Arrangements OR Circuits FOR Control OF Indicating Devices Using Static Means TO Present Variable Information 1

Top 5 of 5 technology areas

Where it ranks

Overall rank by patents

#31,108

of 49,997 tracked assignees

Innovation Score

46.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Burke Neurological Institute's patent record in context - here's where to go next.

Burke Neurological Institute's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 75% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #31,108 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Burke Neurological Institute against Bryx, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 46.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.